Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu. - Wikidata - wikimedia - TriplyDB

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

http://www.wikidata.org/entity/Q34375622

about

Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.PET Radiometals for Antibody Labeling.

P2860

Q48136353-A05E4692-B32B-4CCE-BE98-AF7562EC97F3 Q48228929-7CE38FE5-3BFF-42C2-8BF1-81FE81D0F4B8

P2860

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

http://www.wikidata.org/entity/Q34375622

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@ast

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@en

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@nl

type

label

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@ast

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@en

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@nl

prefLabel

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@ast

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@en

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

@nl

P1433

Q34375622-5BDAC04F-6188-4492-A96B-1399BD4DB0EF

P1476

Q34375622-055DC27B-9004-4522-A73B-90A237E78474

P2093

Q34375622-1F1D187A-54AB-466A-AE47-F2CC5CC66A0A

Q34375622-2A357D73-0726-4266-ACAF-03A31AD071D8

Q34375622-2F8AB27B-12FB-4397-9F8A-095D48DE9FC6

Q34375622-4650ACF0-729B-4487-A6A1-75D6B576AB92

Q34375622-5F8EABBC-D3CC-4543-84AE-A705A674AF84

Q34375622-60A9BB3C-740B-4197-984D-31FB2B08C6F3

Q34375622-90EE52FF-2188-473A-8746-5725F75194B2

Q34375622-DE2FBB6A-9CF5-4D27-B3E6-5E5AEEE3593B

P2860

Q34375622-39ABE325-4066-404A-AFA5-4FCA915FA1E6

Q34375622-3A6778D2-BFC1-4F25-97EE-89D80FDE99EA

Q34375622-3D773CEF-8FA4-415E-A7D5-B038DA137D9C

Q34375622-483B674A-C799-4785-B0B5-8E67335A7234

Q34375622-5D1C2F81-B476-4DED-A8ED-0E024C4996B4

Q34375622-671D7200-CD2D-42AC-8598-AE423662CD32

Q34375622-8B39F8B3-9E05-4AFD-A12D-ED98E8ADEE5C

Q34375622-95D5FDE5-E7BB-48AF-8AC2-6418996140B6

Q34375622-A3DE889B-A5A6-480E-A139-C5F349A4B186

Q34375622-F2B2F698-527C-4E77-9311-E4B6F3C0DC12

P2888

Q34375622-98555741-803F-4330-9B90-B7F049EE54C0

P304

Q34375622-BB7B1300-3725-4B32-AE7D-20FE7D561AEC

P31

Q34375622-EDAD827F-DB11-461B-A429-F43A60A339E0

P356

Q34375622-E39E6E9F-F019-467D-81BC-19C4C4CA3C7A

P407

Q34375622-5CCDABA8-1113-4954-B539-E6C5F15E2381

P478

Q34375622-39965264-A3A7-4667-8ED7-4A486954E458

P50

Q34375622-45896F20-1982-42C5-B97C-8D193EDAC7D4

P577

Q34375622-4681F0D9-1E78-4948-838E-E8A767964513

P5875

Q34375622-5EBDC078-2DB2-4738-91A4-5DA685A57E1A

P6179

Q34375622-673B0C57-4D2D-42A4-884A-5BB40C093E30

P698

Q34375622-490E92F3-2711-45BF-900D-CC0B0E207C7F

P932

Q34375622-32A14ED6-A4BB-4E8C-985D-876669BECBFD

P356

P1433

Scientific Reports

P1476

Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu

@en

P2093

Aranh Pen

http://www.w3.org/2001/XMLSchema#string

David J Morrissey

http://www.w3.org/2001/XMLSchema#string

Graham F Peaslee

http://www.w3.org/2001/XMLSchema#string

Lee G Sobotka

http://www.w3.org/2001/XMLSchema#string

Nick Wozniak

http://www.w3.org/2001/XMLSchema#string

Scott Essenmacher

http://www.w3.org/2001/XMLSchema#string

Shaun Loveless

http://www.w3.org/2001/XMLSchema#string

Tara Mastren

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.

Copper-67 as a therapeutic nuclide for radioimmunotherapy.

Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.

The production, separation, and use of 67Cu for radioimmunotherapy: a review.

Comparison of bifunctional chelates for (64)Cu antibody imaging.

Radionuclide development at BNL for nuclear medicine therapy.

Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).

Cross-section measurements of the nuclear reactions natZn(d,x)64Cu, 66Zn(d,alpha)64Cu and 68Zn(p,alphan)64Cu for production of 64Cu and technical developments for small-scale production of 67Cu via the 70Zn(p,alpha)67Cu process.

Behaviour of vanadate and vanadium-transferrin complex on different anion-exchange columns. Application to in vivo 48V-labelled rat serum.

Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.

P2888

P304

6706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP06706

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267273015

http://www.w3.org/2001/XMLSchema#string

P6179

1047371963

http://www.w3.org/2001/XMLSchema#string

P698

25330839

http://www.w3.org/2001/XMLSchema#string

P932

4204030

http://www.w3.org/2001/XMLSchema#string